Trademark applications and grants for Aveo Pharmaceuticals, Inc.. Aveo Pharmaceuticals, Inc. has 33 trademark applications. The latest application filed is for "a symbol or image mark"
State Incorporated | DELAWARE |
Entity Type | CORPORATION |
Address | 1 Broadway, 14th Floor Cambridge, MASSACHUSETTS UNITED STATES 02142 |
Patent Application | Date |
---|---|
ANTI-NOTCH3 ANTIBODY 20220235127 - 17/450282 Okamura; Heidi ;   et al. | 2022-07-28 |
USE OF TIVOZANIB TO TREAT SUBJECTS WITH REFRACTORY CANCER 20220233516 - 17/720619 Bailey; Michael P. ;   et al. | 2022-07-28 |
USE OF TIVOZANIB TO TREAT SUBJECTS WITH REFRACTORY CANCER 20220000858 - 17/289913 Bailey; Michael P. ;   et al. | 2022-01-06 |
ANTI-NOTCH3 ANTIBODIES 20210171627 - 16/992897 Okamura; Heidi ;   et al. | 2021-06-10 |
ANTI-GDF-15 ANTIBODIES 20210101968 - 16/824034 Lerner; Lorena ;   et al. | 2021-04-08 |
NCAGE Code | 4XXL9 | AVEO PHARMACEUTICALS INC. |
CAGE Code | 4XXL9 | AVEO PHARMACEUTICALS, INC. |
SEC | 0001325879 | AVEO PHARMACEUTICALS INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.